News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Masson-Hurlburt Elizabeth
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Masson-Hurlburt Elizabeth (EVP, Head of Clinical Ops) has filed a Form 4 on CorMedix Inc.|
Txns:
| Sold 8,000 shares
@ $6.9242, valued at
$55.4k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2020 |
4
| Masson-Hurlburt Elizabeth (EVP, Head of Clinical Ops.) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 37,500 options to buy
@ $5.63, valued at
$211.1k
Granted 37,500 options to buy
@ $4.08, valued at
$153k
|
|
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2019 |
4
| Masson Elizabeth (EVP, Head of Clinical Ops.) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 120,000 options to buy
@ $1.66, valued at
$199.2k
|
|
| 12/06/2018 |
4
| Masson Elizabeth (EVP, Head of Clinical Ops.) has filed a Form 4 on CorMedix Inc.|
Txns:
| Exercised 40,000 options to buy
@ $0.29, valued at
$11.6k
|
|
| 04/09/2018 |
4
| Masson Elizabeth (EVP, Head of Clinical Ops.) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 310,000 options to buy
@ $0.29, valued at
$89.9k
|
|
| 04/09/2018 |
3
| Masson Elizabeth (EVP, Head of Clinical Ops.) has filed a Form 3 on CorMedix Inc. |
|
|